{"schema_version":"secwatch.filing_event.v1","accession":"0001380106-26-000067","form_type":"8-K","ticker":"RPID","cik":"0001380106","company_name":"RAPID MICRO BIOSYSTEMS, INC.","filed_at":"2026-05-13T20:33:24+00:00","discovered_at":"2026-05-13T20:34:18.442869+00:00","generated_at":"2026-05-13T20:34:52.340749+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Rapid Micro Biosystems Q1 revenue up 11% to $8.0M; net loss widens to $14.3M","bullets":["Total revenue $8.0M (+11% YoY); product revenue $5.6M (+36%).","Net loss $14.3M ($0.31/sh) vs $11.3M ($0.26/sh) in Q1 2025.","Recurring revenue $5.1M (+28%), 63% of total; placed 6 Growth Direct systems (3 in Q1 2025).","Gross margin 4.6% vs 5.6% last year; cash and equivalents $23M.","Reaffirms FY2026 guidance: revenue $37-41M, 30-38 system placements, ~20% gross margin."],"urls":{"canonical":"https://secwatch.observer/filing/0001380106-26-000067","json":"https://secwatch.observer/filing/0001380106-26-000067.json","markdown":"https://secwatch.observer/filing/0001380106-26-000067.md","text":"https://secwatch.observer/filing/0001380106-26-000067.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1380106/000138010626000067/0001380106-26-000067-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1380106/000138010626000067/rpid-20260513.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-13T20:34:52.340749+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0b84c4d7212375ea9cd7b7073abeefd49c2867dd","claim":"RAPID MICRO BIOSYSTEMS, INC. reported full year 2026 results: revenue full year 2026 total revenue guidance range of $37.0 million to $41.0 million. Guidance reaffirmed.","evidence_excerpt":"Reaffirms full year 2026 total revenue guidance range of $37.0 million to $41.0 million including a range of 30 to 38 Growth Direct system placements","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1380106/000138010626000067/0001380106-26-000067-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2026"},{"label":"Revenue","value":"full year 2026 total revenue guidance range of $37.0 million to $41.0 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"ae3eed89ad7fb01da2d3f422cef135592f29aa97","claim":"RAPID MICRO BIOSYSTEMS, INC. reported first quarter ended March 31, 2026 results: revenue Total revenue for the first quarter of 2026 increased 11.1% to $8.0 million compared to $7.2 million in the first quarte, net income Net loss for the first quarter of 2026 was $14.3 million, EPS net loss per share was $0.31.","evidence_excerpt":"Total revenue for the first quarter of 2026 increased 11.1% to $8.0 million compared to $7.2 million in the first quarter of 2025.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1380106/000138010626000067/0001380106-26-000067-index.htm","confidence":0.99,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2026"},{"label":"Revenue","value":"Total revenue for the first quarter of 2026 increased 11.1% to $8.0 million compared to $7.2 million in the first quarte"},{"label":"Net income","value":"Net loss for the first quarter of 2026 was $14.3 million"},{"label":"EPS","value":"net loss per share was $0.31"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"ae3eed89ad7fb01da2d3f422cef135592f29aa97","claim":"RAPID MICRO BIOSYSTEMS, INC. reported first quarter ended March 31, 2026 results: revenue Total revenue for the first quarter of 2026 increased 11.1% to $8.0 million compared to $7.2 million in the first quarte, net income Net loss for the first quarter of 2026 was $14.3 million, EPS net loss per share was $0.31.","evidence_excerpt":"Net loss for the first quarter of 2026 was $14.3 million and net loss per share was $0.31, compared to a net loss of $11.3 million and net loss per share of $0.26 in the first quarter of 2025.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1380106/000138010626000067/0001380106-26-000067-index.htm","confidence":0.99,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2026"},{"label":"Revenue","value":"Total revenue for the first quarter of 2026 increased 11.1% to $8.0 million compared to $7.2 million in the first quarte"},{"label":"Net income","value":"Net loss for the first quarter of 2026 was $14.3 million"},{"label":"EPS","value":"net loss per share was $0.31"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}